Melanoma
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
Latest News
FDA Approves First Cellular Therapy for Metastatic Melanoma
Patients with metastatic melanoma have potential new treatment option with approval of T-cell immunotherapy.
Latest News
Despite Good Prognosis, Early Melanoma Sparks Fear of Recurrence
In a small study, patients successfully treated for early, localized cutaneous melanoma expressed anxieties about recurrence, life changes, and...
Latest News
Expert Hopes to Expand Ohio Model of Melanoma Case Reporting
“This is an opportunity to improve state health, quality improvement projects, help providers, and gain recognition as a center of excellence,” Dr...
Make the Diagnosis
A 74-year-old White male presented with a 1-year history of depigmented patches on the hands, arms, and face, as well as white eyelashes and eyebrows
The patient's medical history was significant for a 2.2-mm ulcerated melanoma on the left chest 6 years prior to presentation.
Latest News
Despite An AI Assist, Imaging Study Shows Disparities in Diagnosing Different Skin Tones
The study involved 389 board-certified dermatologists and 450 primary care physicians in 39 countries.
Latest News
While Rare, Periocular Melanoma May Be Slightly Increasing
Most cases involve the intraocular part of the eye and the uvea.
Latest News
More Than 100K New Cutaneous Melanoma Diagnoses Expected in 2024
Individuals can track their UV exposure with a variety of wearable devices and apps.
Latest News
Study Concludes Most Melanoma Overdiagnoses Are In Situ
The increase in melanoma diagnoses in the United States, while mortality has remained flat, has raised concerns about overdiagnosis of melanoma,...
Commentary
Skin Cancer Screening: The Paradox of Melanoma and Improved All-Cause Mortality
In April 2023, the US Preventive Services Task Force (USPSTF) issued a controversial recommendation that the current evidence is insufficient to...
Feature
Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations
Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.